Project Grant K23EY036499
- Federal Grant Award Summary Oregon Health & Science University received a $875,918 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop, evaluate, and validate large language models (LLMs) for extracting clinical data related to amblyopia treatment, adherence, and outcomes from electronic health records. Amblyopia, a common pediatric vision disorder affecting 2-4% of the population, can be effectively treated but is often limited by...
- This Project Grant award for $383,000 from the National Eye Institute (CFDA 93.867 - Vision Research) aims to identify social determinants of health (SDOH) indicators associated with disparities in the diagnosis, management, and prognosis of dry eye disease. The project will leverage electronic health record data from a single-center and multi-center (Sight Outcomes Research Collaborative) datasets to build prognostic models that account for individual and structural barriers to accessing eye...
- Federal Grant Award Summary Children's Hospital Medical Center of Akron received a $786,350 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025, through August 31, 2027. The award supports the implementation and expansion of instrument-based vision screening in primary care pediatric offices across 44 general pediatric practices affiliated with Akron Children's Hospital. This initiative addresses the critical gap in...
- Federal Grant Award Summary Boston Children's Hospital received a $136,512 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) effective July 1, 2025, through June 30, 2027. The award supports research investigating how intrinsically photosensitive retinal ganglion cells (ipRGCs) transform light information in melanopsin pathways to regulate physiological and behavioral responses. The research employs advanced imaging techniques to measure...
- The National Eye Institute (NEI) awarded a $295,766 Project Grant (CFDA 93.867 - Vision Research) to Ther-Ai LLC, located in Oviedo, FL, to develop a smartphone application called ILIGN. The goal of this project is to create a rapid, non-invasive, and accurate artificial intelligence-driven system to pre-screen for ocular misalignment (strabismus), a leading cause of preventable blindness in children. The expected outcome is a software platform that allows untrained end-users to diagnose...
- Summary The National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), awarded $417,162 to the University of Houston System for a two-year project (July 1, 2025 – June 30, 2027) investigating the birefringence properties of the lamina cribrosa and posterior eye structures as they relate to glaucoma detection and diagnosis. The project addresses a critical clinical need by developing advanced optical imaging methodologies to detect early structural and stress-related changes...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant totaling $168,053 to The Washington University (Office of Sponsored Research Services) on July 29, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a five-year research initiative (through June 30, 2030) investigating refractive surgery as a therapeutic intervention for children with Autism Spectrum...
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded The Washington University a $855,250 Project Grant effective September 1, 2025, through August 31, 2027, to conduct exploratory research on enhancing efferocytosis (cellular debris clearance) as a therapeutic approach for oxygen-induced retinopathy (OIR). The research addresses retinopathy of prematurity (ROP), a leading cause of childhood blindness resulting from supplemental...
- Federal Cooperative Agreement Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a cooperative agreement of $471,606 to the University of Houston System, with an award date of August 1, 2025, and a completion date of July 31, 2030. This two-year multi-center randomized clinical trial aims to determine whether 0.05% atropine eye drops administered nightly to pre-myopic children ages 6-11 can delay the onset of myopia (nearsightedness). The...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded the National Opinion Research Center (NORC) a Project Grant of $493,642 under the Vision Research program (CFDA 93.867) to identify and analyze geographic clusters of vision and eye health problems using secondary surveillance data. The project, which commenced September 1, 2025 and extends through August 31, 2027, develops analytical tools and methodologies to systematically identify high-prevalence regions and...
SOCIAL DETERMINANTS OF VISION HEALTH IN CHILDREN - PROJECT SUMMARY AMBLYOPIA IS THE LEADING CAUSE OF VISION LOSS IN CHILDREN. DELAYED DIAGNOSIS AND/OR INADEQUATE TREATMENT OF AMBLYOPIA IN EARLY CHILDHOOD MAY RESULT IN PERMANENT VISION LOSS. CHILDREN FROM HISTORICALLY MARGINALIZED COMMUNITIES ARE AT INCREASED RISK OF PREVENTABLE VISION LOSS. HOWEVER, THE UNDERLYING SOCIAL DETERMINANTS OF HEALTH CONTRIBUTING TO THE RACIAL, ETHNIC, AND SOCIOECONOMIC DISPARITIES IN THE VISUAL OUTCOMES OF AMBLYOPIC CHILDREN ARE POORLY UNDERSTOOD. THERE IS AN URGENT NEED TO UNDERSTAND THE FACTORS CONTRIBUTING TO DIAGNOSTIC DELAY AND TREATMENT FAILURE IN AMBLYOPIA - AN EFFORT THAT MAY OFFER NOVEL OPPORTUNITIES FOR COMMUNITY-BASED INTERVENTIONS AND VISION SCREENING POLICIES THAT PROMOTE HEALTH EQUITY. THIS PROPOSAL AIMS TO INVESTIGATE THE DELIVERY OF PREVENTIVE VISION CARE IN THE US AND DEVELOP TOOLS TO IDENTIFY CHILDREN AT RISK OF PREVENTABLE VISION LOSS. THIS RESEARCH WILL LEVERAGE AN ARRAY OF LARGE DATA SOURCES - INCLUDING NATIONALLY REPRESENTATIVE SURVEYS, INSURANCE CLAIMS, AND ELECTRONIC HEALTH RECORDS - TO IDENTIFY MODIFIABLE FACTORS THAT MAY IMPROVE THE VISUAL OUTCOMES OF CHILDREN WITH AMBLYOPIA FROM HISTORICALLY MARGINALIZED COMMUNITIES. THE CENTRAL HYPOTHESIS IS THAT HOUSEHOLD- AND NEIGHBORHOOD-LEVEL SOCIAL DETERMINANTS OF HEALTH INFLUENCE THE RECEIPT OF VISION SCREENING (AIM 1), ACCESS TO EYE SPECIALTY CARE (AIM 2), AND TREATMENT SUCCESS (AIM 3). THE INVESTIGATIONS WILL EVALUATE EXISTING VISION SCREENING POLICIES IN THE US, IDENTIFY GEOSPATIAL BARRIERS TO HEALTH CARE ACCESS, AND HELP DEVELOP A PREDICTION MODEL TO IDENTIFY CHILDREN AT HIGH RISK FOR VISION LOSS FROM AMBLYOPIA. THE CANDIDATE, DR. ISDIN OKE, IS A PEDIATRIC OPHTHALMOLOGIST, DATA SCIENTIST, AND HEALTH SERVICES RESEARCHER WHOSE LONG-TERM GOAL IS TO BECOME AN INDEPENDENT INVESTIGATOR WITH EXPERTISE IN DATA-DRIVEN APPROACHES TO REDUCE PREVENTABLE VISION LOSS IN CHILDREN. THE CAREER DEVELOPMENT PLAN WILL PROVIDE EXPERTISE IN STUDY DESIGN, RESEARCH METHODS, AND ADVANCED BIOSTATISTICAL APPROACHES FOR CONDUCTING HEALTH EQUITY RESEARCH. THE MENTORSHIP TEAM INCLUDES EXPERTISE IN HEALTH SERVICES RESEARCH, VISION SCREENING, SOCIAL EPIDEMIOLOGY, GEOSPATIAL ANALYSES, AND PREDICTIVE MODELING. THE TRAINING ENVIRONMENT AT BOSTON CHILDREN'S HOSPITAL AND HARVARD MEDICAL SCHOOL PROVIDES ACCESS TO RICH DATA SOURCES AND COMPUTATIONAL INFRASTRUCTURE. THE UNIQUE COMBINATION OF THE TRAINING PLAN, MENTORSHIP TEAM, AND INSTITUTIONAL ENVIRONMENT WILL ACCELERATE THE CANDIDATE'S DEVELOPMENT INTO AN NIH- FUNDED INDEPENDENT INVESTIGATOR AND LEADER IN DATA SCIENCE AND HEALTH DISPARITIES RESEARCH IN OPHTHALMOLOGY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||